Hear Verily public health expert Amy Lockwood at the Council of State and Territorial Epidemiologists (CSTE) Annual Conference discuss wastewater monitoring for infectious disease, outbreaks, and public health decision-making at the sessions listed below. You can also book a meeting with Amy and connect with her at booth #108. ✳️ Monday, June 9 at 10:45 AM The Power of Wastewater Monitoring for Public Health Decision-Making ✳️ Tuesday, June 10 at 10:45 AM From Sewage to Symptoms: Advancing Wastewater Monitoring for Public Health Action ✳️ Tuesday, June 10 at 1:00 PM Introduction to Wastewater Monitoring for Infectious Disease ✳️ Wednesday, June 11 at 1:00 PM Leveraging Wastewater Monitoring to Respond to the H5N1 Outbreak
Siloed systems and compliance obligations can hinder data sharing in healthcare. Our new blog post discusses how to overcome these challenges and foster a faster pipeline of discoveries and potential treatments by unlocking the value of your data.
Wastewater testing of samples from January 2025 detected measles in Houston before reported cases, demonstrating the power of wastewater monitoring for early outbreak detection. Researchers from Baylor College of Medicine and collaborators used a sequencing-based approach to identify the virus. Verily now offers sensitive and reliable wastewater monitoring for the measles virus, providing timely insights into community health.
Learn how Verily can unlock the value of biomedical data by breaking down data silos in a live webinar with Verily experts David Glazer and Shimon Rura on June 3 at 9:30 AM PT.
Clinical trials are notoriously inefficient, expensive, and dependent on research sites that are overburdened with cumbersome processes and technology. Watch how Verily and the American Oncology Network are supporting research aimed at bringing new treatments to market faster, helping to preserve our most precious resource — time.
We congratulate Scott Burke, Verily Chief Technology Officer, for being named to The Healthcare Technology Report list of Top 25 Healthcare AI Executives of 2025! Scott leads Verily’s Technology org across software, hardware, AI and data science, IT, and security. He and fellow leaders are recognized for applying artificial intelligence to healthcare, with the ultimate goal of improving patient outcomes.
The Verily team was excited to participate in the Regeneron Digital Biomarker Summit this week! Sooyoon Shin, Senior Manager, Digital Biomarkers, gave a fantastic talk on our approach to measuring Parkinson’s disease progression in clinical trials using active and passive digital endpoints with Numetric Digital Measures.
For data scientists working in healthcare, the ability to govern, analyze and collaborate on the right data remains a challenge, and can slow down the pace of biomedical research. Platforms like Verily Workbench provide the infrastructure and collaborative tools to unlock the value of multimodal health data at scale, enabling biomedical research.
Together with The Michael J. Fox Foundation for Parkinson's Research (MJFF), we’re expanding the impact of the Personalized Parkinson’s Project (PPP), a two-year study of 520 people with Parkinson’s led by Verily and Radboud University Medical Center. Recently, we received a $14.7M grant to generate a comprehensive molecular dataset from the PPP. The data will be made available to researchers globally using Verily’s Workbench platform, aiming to improve understanding and treatment of Parkinson’s disease.
Measles cases are rising in the US, posing a significant public health risk. Early detection is critical to help mitigate the spread. With the development of a new assay, Verily Sightline now offers wastewater monitoring for measles, enabling early warning and ongoing monitoring to inform public health strategies and communications.
